Physiological and pathological functions of a novel prion-like protein, PrPLP/Dpl.
新型朊病毒样蛋白 PrPLP/Dpl 的生理和病理功能。
基本信息
- 批准号:13470065
- 负责人:
- 金额:$ 9.15万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Certain lines of mice devoid of prion protein (PrP), such as Ngsk Prnp^<0/0>, exhibit late-onset ataxia due to Purkinje cell degeneration, which is rescued by a transgene encoding PrP. In these mice, PrP-like protein, PrPLP/Dpl, is ectopically expressed by neurons including Purkinje cells and glial cells. To explore mechanisms of the neurodegeneration, two types of transgenic (tg) mice expressing PrPLP/Dpl in all neurons, tg(N-PrPLPIDpI), or only Purkinje cells, tg(P-PrPLP/Dpl), were generated and subsequently backcrossed with non-ataxic Zrch I Prnp^<0/0> mice to eliminate the Prnp alleles. In contrast to the tg mice with the Prnp^<+/+> background, never showing neurological abnormalities, not only tg(N-PrPLP/Dpl) but also, tg(P-PrPLP/Dpl) mice with the Prnp^<0/0> alleles developed Purkinje cell degeneration after incubation periods inversely correlated to the expression levels of PrPLP/Dpl. Moreover, some of the tg mice hemizygous for Prnp allele (Prnp^<0+>) also succumbed to the dise … More ase but much later than those carrying the Prnp^<0/0> alleles. These results indicated that PrPLP/Dpl ectopically expressed by Purkinje cells itself executes a does-dependent deleterious effect on the cells, and that a stoichiometric antagonistic interaction between PrP and PrPLP/Dpl is crucially involved in the neurodegeneration. We next introduced five types of PrP transgenes including heterologous hamster and two mouse/hamster chimeric genes as well as two mutants, each of which encoded PrP lacking residues 23-88 (MHM2.del23-88) or with E199K substitution (Mo.E199K), into Ngsk Prnp^<0/0> mice. Only MHM2.de123-88 failed to rescue from the Purkinje cell death. Little difference was observed in pathology and onset of ataxia between Ngsk Prnp^<0/0> and MHM2.de123-88/Ngsk Prnp^<0/0>. No detergent-insoluble PrPLP/Dpl was detectable in the CNS of Ngsk Prnp^<0/0> even after the onset of ataxia. Our findings provide evidence that the N-terminal residues 23-88 of PrP containing the unique octapeptide-repeat region is crucial for preventing Purkinje cell death in the Prnp^<0/0> mice expressing PrPLP/Dpl in the neuron. Less
某些没有原始蛋白质(PRP)的小鼠(例如NGSK PRNP^<0/0>)是由于Purkinje细胞变性而暴露的晚期性共济失调,这是由编码PRP的转基因响应的。在这些小鼠中,PRP样蛋白PRPLP/DPL是由包括Purkinje细胞和神经胶质细胞在内的神经元表达的。为了探索神经退行性的机制,在所有神经元中表达PRPLP/DPL的两种类型的转基因(TG)小鼠,或仅生成非触发Zrch I Prnp^<0/0/0/0/0/0/0/0/0/0/purkinje细胞TG(PPRPLP/DPL)均产生,并随后将其全部反向。 In contrast to the tg mice with the Prnp^<+/+> background, never showing neurologic abnormalities, not only tg(N-PrPLP/Dpl) but also, tg(P-PrPLP/Dpl) mice with the Prnp^<0/0> alleles developed Purkinje cell degeneration after incubation periods inversely correlated to the expression levels of PrPLP/Dpl.此外,某些TG小鼠在PRNP等位基因(PRNP^<0+>)中也屈服于Disse…ASE…比携带PRNP^<0/0>等位基因的TG小鼠。这些结果表明,由Purkinje细胞本身以生态表达的PRPLP/DPL对细胞执行依赖性有害作用,并且PRP和PRPLP/DPL之间的化学计量拮抗相互作用完全参与神经变性。接下来,我们介绍了五种类型的PRP翻译,包括异源仓鼠和两个鼠标/仓鼠嵌合基因以及两个突变体,每个突变体编码的PRP缺乏保留23-88(MHM2.DEL23-88)或E199K替代(MO.E199K)(MO.E199K)(MO.E199K)(MO.E199K)(ngsk prnp prnp prnp prnp^<0/0/0> mice)。只有MHM2.DE123-88才能从Purkinje细胞死亡中救出。 NGSK PRNP^<0/0>和MHM2.DE123-88/ngsk PRNP^<0/0>之间的病理和共济失调的病理和共济失调的发作几乎没有差异。即使在共济失调开始后,也可以在NGSK PRNP^<0/0>的CNS中检测到无法确定不可差的PRPLP/DPL。我们的发现提供了证据表明,N端保留了23-88个含有独特的八肽肽重复区域的PRP,对于防止在神经元中表达PRPLP/DPL的PRNP^<0/0>小鼠中的Purkinje细胞死亡至关重要。较少的
项目成果
期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Lehmann S: "Ex vivo transmission of mouse-adapted prion strains to N2a and GT1-7 cell lines"Alzheimer's Disease : Advances in Etiology, Pathogenesis and Therapeutics. 679-686 (2001)
Lehmann S:“小鼠适应的朊病毒株离体传播至 N2a 和 GT1-7 细胞系”阿尔茨海默氏病:病因学、发病机制和治疗学的进展。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Atarashi, R., Sakaguchi, S., Shigematsu, K., Arima, K., Okimura, N., Yamaguchi, N., Li, A., Kopacek, J., Katamine, S: "Abnormal activation of glial cells in the brains of prion protein-deficient mice ctopically expressing prion protein-like protein, PrPLP
Atarashi, R.、Sakaguchi, S.、Shigematsu, K.、Arima, K.、Okimura, N.、Yamaguchi, N.、Li, A.、Kopacek, J.、Katamine, S:“神经胶质细胞的异常激活
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Atarashi, R., Sakaguchi, S., Shigematsu, K Anima, K., Okimura, N., Yamaguchi, N.Li, A., Kopacek, J., Katamine, S.: "Abnormal activation of glial cells in the brains of prion protein-deficient mice ectopically expressing prion protein-like protein, PrPLP/D
Atarashi, R.、Sakaguchi, S.、Shigematsu、K Anima, K.、Okimura, N.、Yamaguchi, N.Li, A.、Kopacek, J.、Katamine, S.:“神经胶质细胞的异常激活
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yukitake M, Satoh J, Katamine S, Kuroda Y: "EAAT4 mRNA expression is preserved in the cerebellum of prion protein-deficient mice."Neurosci Lett. 352(3). 171-174 (2003)
Yukitake M、Satoh J、Katamine S、Kuroda Y:“EAAT4 mRNA 表达保留在朊病毒蛋白缺陷小鼠的小脑中。”Neurosci Lett。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yukitake M, Satoh J, Katamine S, Kuroda Y: "EAAT4 mRNA expression is preserved in the cerebellum.of prion protein-deficient mice."Neurosci Lett.. 352(3). 171-174 (2003)
Yukitake M、Satoh J、Katamine S、Kuroda Y:“EAAT4 mRNA 表达保留在朊病毒蛋白缺陷小鼠的小脑中。”Neurosci Lett.. 352(3)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATAMINE Shigeru其他文献
KATAMINE Shigeru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATAMINE Shigeru', 18)}}的其他基金
Biological studies on prions
朊病毒的生物学研究
- 批准号:
16017281 - 财政年份:2004
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Structure-based drug designs for the treatment of prion disease
用于治疗朊病毒病的基于结构的药物设计
- 批准号:
16209017 - 财政年份:2004
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Molecular Mechanisms for Purkinje Cell Degeneration and Demyelination in Prion Protein-Deficient Mice.
朊病毒蛋白缺陷小鼠浦肯野细胞变性和脱髓鞘的分子机制。
- 批准号:
11694292 - 财政年份:1999
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
MECHANISMS OF NEUTONAL CELL DEATH IN PRION PROTEIN-LESS MICE
无朊病毒蛋白小鼠中性细胞死亡的机制
- 批准号:
09044321 - 财政年份:1997
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for international Scientific Research
MOLECULAR MECHANISMS FOR PRION PROTEIN CONVERSION AND CELL-TYPES INVOLVED IN THE CONVERSION IN VIVO
朊病毒蛋白体内转化的分子机制和参与转化的细胞类型
- 批准号:
09470154 - 财政年份:1997
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
基于prion构象转变的分子机理设计和发现调控朊蛋白错误折叠和聚集的小分子和肽类抑制剂
- 批准号:21675070
- 批准年份:2016
- 资助金额:65.0 万元
- 项目类别:面上项目
酵母prion蛋白Ure2的寡聚及构象变化的单分子水平研究
- 批准号:21673278
- 批准年份:2016
- 资助金额:65.0 万元
- 项目类别:面上项目
APP/PS1双转基因阿尔茨海默氏病鼠的神经发生与Prion蛋白的关系
- 批准号:81300923
- 批准年份:2013
- 资助金额:21.5 万元
- 项目类别:青年科学基金项目
细胞型朊蛋白介导Aβ寡聚体神经毒性的信号转导机制研究
- 批准号:81100246
- 批准年份:2011
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
蛋白激酶在FFI病人脑中表达量的变化及其机制研究
- 批准号:81101302
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A Novel Gene Therapy Approach to Prevent Alpha-synuclein Misfolding in Multiple System Atrophy
一种防止多系统萎缩中α-突触核蛋白错误折叠的新基因治疗方法
- 批准号:
10673418 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Tau protein proteolysis signaling in Alzheimer's disease
阿尔茨海默病中的 Tau 蛋白水解信号
- 批准号:
10728202 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity
饮食诱导肥胖中 ALCAT1 激活 NLRP3 的细胞机制
- 批准号:
10658507 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Mechanisms of Toxicity Induced by EWS/FLI1 Overdose in Ewing Sarcoma
EWS/FLI1 过量引起尤文肉瘤的毒性机制
- 批准号:
10719095 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Activity-dependent release of human alpha-synuclein
人类 α-突触核蛋白的活性依赖性释放
- 批准号:
10575119 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别: